Global Transcriptional Analysis for Biomarker Discovery and Validation in Cellular Therapies

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Diagnosis & Therapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF03256324PMID 19650671PMCID PMC2949270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures.

  2009cited by this paper
• Committee for Medicinal Products for Human Use (CHMP) assessment on efficacy of antidepressants.

  2009cited by this paper
• Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene ExpressionMartinez FO, Gordon S, Locati M, et al (Univ of Milan, Italy; Univ of Oxford, England) J Immunol 177:7303–7311, 2006§

  2008cited by this paper
• AMD3100 and Granulocyte Colony Stimulating Factor (G-CSF) Mobilize Different CD34+ Cell Populations Based on Global Gene and Micro RNA Expression.

  2008cited by this paper
• Clinical-scale Lentiviral Vector Transduction of PBL for TCR Gene Therapy and Potential for Expression in Less-differentiated Cells

  2008cited by this paper
• Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool

  2008cited by this paper
• Evaluation of gene expression profiles of immature dendritic cells prepared from peripheral blood mononuclear cells

  2008influential reference
• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008cited by this paper
• The Impact of Constitutional Copy Number Variants in Myeloma

  2008cited by this paper
• Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection

  2007cited by this paper
• Cell transplantation for treatment of left-ventricular dysfunction due to ischemic heart failure: from bench to bedside

  2007cited by this paper
• Immunomodulation by mesenchymal stem cells and clinical experience

  2007cited by this paper
• Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells.

  2007influential reference
• Gene expression profiling of cutaneous wound healing

  2007cited by this paper
• Dendritic cell vaccines for leukemia patients

  2007cited by this paper
• Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.

  2007cited by this paper
• Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets

  2006cited by this paper
• Gene therapy for primary immunodeficiency diseases: recent progress and misgivings.

  2006cited by this paper
• Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

  2006cited by this paper
• The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics.

  2006cited by this paper
• Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1

  2006cited by this paper
• Adoptive Transfer of Vaccine-Induced Peripheral Blood Mononuclear Cells to Patients with Metastatic Melanoma following Lymphodepletion1

  2006cited by this paper
• Quality prediction of cell substrate using gene expression profiling.

  2006cited by this paper
• Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer.

  2006cited by this paper
• CD34+ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control

  2006influential reference
• AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.

  2006cited by this paper
• Molecular diagnosis of Burkitt's lymphoma.

  2006cited by this paper
• Cytokines and hematopoietic stem cell mobilization

  2006cited by this paper
• Common cancer biomarkers.

  2006cited by this paper
• Manufacturing and quality control of cell-based tumor vaccines: a scientific and a regulatory perspective.

  2006cited by this paper
• Cytokine gene polymorphism in human disease: on-line databases, Supplement 3

  2006cited by this paper
• Correlation between DNA Repair Capacity in Lymphocytes and Acute Side Effects to Skin during Radiotherapy in Nasopharyngeal Cancer Patients

  2005cited by this paper
• MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation.

  2005cited by this paper
• Polarized monocyte response to cytokine stimulation

  2005cited by this paper
• Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

  2005cited by this paper
• Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer.

  2005cited by this paper
• MicroRNAs 221 and 222 Inhibit Normal Erythropoiesis and Erythroleukemic Cell Growth Via Kit Receptor Downmodulation.

  2005influential reference
• Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation.

  2005cited by this paper
• Interleukin-10 Polymorphisms, Cancer Susceptibility and Prognosis

  2005cited by this paper
• The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

  2005cited by this paper
• Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms

  2005cited by this paper
• MicroRNAs Modulate Hematopoietic Lineage Differentiation

  2004cited by this paper
• Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.

  2004cited by this paper
• Forecasting the cytokine storm following systemic interleukin (IL)-2 administration

  2004cited by this paper
• Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms

  2004cited by this paper
• IL-10 stimulatory effects on human NK cells explored by gene profile analysis

  2004cited by this paper
• Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR)

  2003cited by this paper
• Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist.

  2003cited by this paper
• Identification of tissue-specific microRNAs from mouse.

  2002cited by this paper
• Influence of cytokine gene polymorphisms on the development of prostate cancer.

  2002cited by this paper
• Identification of Immune Dominant Cytomegalovirus Epitopes Using Quantitative Real-Time Polymerase Chain Reactions to Measure Interferon-&ggr; Production by Peptide-Stimulated Peripheral Blood Mononuclear Cells

  2002cited by this paper
• The role of quantitative PCR for the immune monitoring of cancer patients

  2002cited by this paper
• IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma

  2001cited by this paper
• Cytokine gene polymorphism in human disease: on-line databases, Supplement 1

  2001cited by this paper
• Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination.

  2000cited by this paper
• High-fidelity mRNA amplification for gene profiling

  2000cited by this paper
• Cytokine gene polymorphism in human disease: on-line databases

  1999cited by this paper
• The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.

  1998cited by this paper
• In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment.

  1998cited by this paper
• The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood

  1997cited by this paper
• Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells.

  1997cited by this paper
• Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

  1996cited by this paper
• A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

  1987cited by this paper
• A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.

  1986cited by this paper
• Journal of Translational Medicine Differentiation of Two Types of Mobilized Peripheral Blood Stem Cells by Microrna and Cdna Expression Analysis

  year unknowncited by this paper

• Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells.

  2016cites this paper
• Chapter 18 – T Cell-Based Gene Therapy of Cancer

  2015cites this paper
• Developing a process control strategy for the consistent and scalable manufacture of human mesenchymal stem cells

  2015cites this paper
• T cell-based gene therapy of cancer.

  2013cites this paper
• Biomarkers in T-cell therapy clinical trials.

  2013cites this paper
• Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development.

  2012cites this paper
• Biomarkers in T cell therapy clinical trials

  2011cites this paper
• Superparamagnetic Iron Oxide Nanoparticles Labeling of Bone Marrow Stromal (Mesenchymal) Cells Does Not Affect Their “Stemness”

  2010cites this paper